Cargando…
Blue-grey hyperpigmentation in acne after vandetanib therapy and doxycycline use: A case report
Vandetanib is an oral tyrosine kinase inhibitor with cutaneous adverse effects that include the development of acne. We present a patient who underwent vandetanib therapy for stage IV medullary thyroid cancer in conjunction with the use of doxycycline for acne that developed. After vandetanib use, b...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943637/ https://www.ncbi.nlm.nih.gov/pubmed/35341100 http://dx.doi.org/10.1177/2050313X221086316 |